BRPI0519330A2 - Ácido nuclÉico isolado; vetor; cÉlula hospedeira; mÉtodo para expressar uma proteÍna; polipeptÍdeo isolado; cromoproteÍna isolada; oligonucleotÍdeo; mÉtodo para identificar um Ácido nuclÉico que codifica uma apoproteÍna de um enediina de nove membros contendo cromoproteÍna; cultura biologicamente pura de actinomadura sp. 21g792 (nrrl 30778); mÉtodo para preparar uma cromoproteÍna; mÉtodo para preparar uma cromoproteÍna modificada; mÉtodo para inibir a progressço de uma doenÇa neoplÁsica em um mamÍfero; composiÇço farmacÊutica; e composto - Google Patents
Ácido nuclÉico isolado; vetor; cÉlula hospedeira; mÉtodo para expressar uma proteÍna; polipeptÍdeo isolado; cromoproteÍna isolada; oligonucleotÍdeo; mÉtodo para identificar um Ácido nuclÉico que codifica uma apoproteÍna de um enediina de nove membros contendo cromoproteÍna; cultura biologicamente pura de actinomadura sp. 21g792 (nrrl 30778); mÉtodo para preparar uma cromoproteÍna; mÉtodo para preparar uma cromoproteÍna modificada; mÉtodo para inibir a progressço de uma doenÇa neoplÁsica em um mamÍfero; composiÇço farmacÊutica; e compostoInfo
- Publication number
- BRPI0519330A2 BRPI0519330A2 BRPI0519330-3A BRPI0519330A BRPI0519330A2 BR PI0519330 A2 BRPI0519330 A2 BR PI0519330A2 BR PI0519330 A BRPI0519330 A BR PI0519330A BR PI0519330 A2 BRPI0519330 A2 BR PI0519330A2
- Authority
- BR
- Brazil
- Prior art keywords
- chromoprotein
- isolated
- nucleic acid
- preparing
- actinomadura
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
ACIDO NUCLÉICO ISOLADO; VETOR; CÉLULA HOSPEDEIRA; MÉTODO PARA EXPRESSAR UMA PROTEÍNA; POLIPEPTÍDEO ISOLADO; CROMOPROTEÍNA ISOLADA; OLIGONUCLEOTÍDEO; MÉTODO PARA IDENTIFICAR UM ÁCIDO NUCLÉICO QUE CODIFICA UMA APOPROTEÍNA DE UM ENEDIINA DE NOVE MEMBROS CONTENDO CROMOPROTEÍNA; CULTURA BIOLOGICAMENTE PURA DE ACTINOMADURA SP. 21G792 (NRRL 30778); MÉTODO PARA PREPARAR UMA CROMOPROTEÍNA; MÉTODO PARA PREPARAR UMA CROMOPROTEÍNA MODIFICADA; MÉTODO PARA INIBIR A PROGRESSçO DE UMA DOENÇA NEOPLÁSICA EM UM MAMÍFERO; COMPOSIÇAO FARMACÊUTICA; E COMPOSTO. A presente invenção refere-se a uma cromoproteina produzida por Actinomadura sp. 21G792, bem como seqúências de aminoácidos e de ácidos nucléicos do componente de apoproteina da cromoproteina e de componentes da via biossintética para o cromáforo. A presente invenção é útil para desenvolver composições farmacêuticas e tratar doenças tais como câncer ou infecções bacterianas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63739104P | 2004-12-17 | 2004-12-17 | |
PCT/US2005/045818 WO2006066153A2 (en) | 2004-12-17 | 2005-12-16 | Actinomadura chromoprotein, apoprotein, and gene cluster |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0519330A2 true BRPI0519330A2 (pt) | 2009-01-20 |
Family
ID=36588624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0519330-3A BRPI0519330A2 (pt) | 2004-12-17 | 2005-12-16 | Ácido nuclÉico isolado; vetor; cÉlula hospedeira; mÉtodo para expressar uma proteÍna; polipeptÍdeo isolado; cromoproteÍna isolada; oligonucleotÍdeo; mÉtodo para identificar um Ácido nuclÉico que codifica uma apoproteÍna de um enediina de nove membros contendo cromoproteÍna; cultura biologicamente pura de actinomadura sp. 21g792 (nrrl 30778); mÉtodo para preparar uma cromoproteÍna; mÉtodo para preparar uma cromoproteÍna modificada; mÉtodo para inibir a progressço de uma doenÇa neoplÁsica em um mamÍfero; composiÇço farmacÊutica; e composto |
Country Status (8)
Country | Link |
---|---|
US (1) | US20080274959A1 (pt) |
EP (1) | EP1836219A2 (pt) |
JP (1) | JP2008523817A (pt) |
CN (1) | CN101175767A (pt) |
AU (1) | AU2005316379A1 (pt) |
BR (1) | BRPI0519330A2 (pt) |
CA (1) | CA2587285A1 (pt) |
WO (1) | WO2006066153A2 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2008016269A (es) * | 2006-06-21 | 2009-06-08 | Wyeth Corp | Fermentacion y purificacion de cromoproteinas actinomadura y especies relacionadas. |
JP5387313B2 (ja) * | 2009-10-08 | 2014-01-15 | 住友ベークライト株式会社 | 成形体の製造方法、成形体、眼鏡および防護製品 |
CN106916835B (zh) * | 2015-12-24 | 2022-08-12 | 武汉合生科技有限公司 | 化合物的生物合成基因簇及其应用 |
CN106916834B (zh) * | 2015-12-24 | 2022-08-05 | 武汉合生科技有限公司 | 化合物的生物合成基因簇及其应用 |
US20190127411A1 (en) | 2016-04-06 | 2019-05-02 | Croda International Plc | Glycolipopeptide biosurfactants |
US10975403B2 (en) | 2017-08-09 | 2021-04-13 | Conagen Inc. | Biosynthesis of eriodictyol from engineered microbes |
CN112359048B (zh) * | 2020-08-27 | 2021-12-28 | 浙江大学 | 一种吕宋肽菌素c的制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5053394A (en) * | 1988-09-21 | 1991-10-01 | American Cyanamid Company | Targeted forms of methyltrithio antitumor agents |
US6583266B1 (en) * | 1993-08-19 | 2003-06-24 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to mycobacterium tuberculosis and leprae for diagnostics and therapeutics |
US6599707B1 (en) * | 1998-09-11 | 2003-07-29 | Exsar Corporation | Methods for identifying hot-spot residues of binding proteins and small compounds that bind to the same |
JP2002045185A (ja) * | 2000-08-02 | 2002-02-12 | Kyowa Hakko Kogyo Co Ltd | F0F1−ATPaseおよび該酵素をコードするDNA |
US7314974B2 (en) * | 2002-02-21 | 2008-01-01 | Monsanto Technology, Llc | Expression of microbial proteins in plants for production of plants with improved properties |
-
2005
- 2005-12-16 AU AU2005316379A patent/AU2005316379A1/en not_active Abandoned
- 2005-12-16 JP JP2007546977A patent/JP2008523817A/ja not_active Withdrawn
- 2005-12-16 CA CA002587285A patent/CA2587285A1/en not_active Abandoned
- 2005-12-16 WO PCT/US2005/045818 patent/WO2006066153A2/en active Application Filing
- 2005-12-16 CN CNA2005800431872A patent/CN101175767A/zh active Pending
- 2005-12-16 US US11/794,068 patent/US20080274959A1/en not_active Abandoned
- 2005-12-16 EP EP05857118A patent/EP1836219A2/en not_active Withdrawn
- 2005-12-16 BR BRPI0519330-3A patent/BRPI0519330A2/pt not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN101175767A (zh) | 2008-05-07 |
WO2006066153A2 (en) | 2006-06-22 |
AU2005316379A1 (en) | 2006-06-22 |
US20080274959A1 (en) | 2008-11-06 |
CA2587285A1 (en) | 2006-06-22 |
EP1836219A2 (en) | 2007-09-26 |
WO2006066153A8 (en) | 2008-10-23 |
WO2006066153A3 (en) | 2007-12-13 |
JP2008523817A (ja) | 2008-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0519330A2 (pt) | Ácido nuclÉico isolado; vetor; cÉlula hospedeira; mÉtodo para expressar uma proteÍna; polipeptÍdeo isolado; cromoproteÍna isolada; oligonucleotÍdeo; mÉtodo para identificar um Ácido nuclÉico que codifica uma apoproteÍna de um enediina de nove membros contendo cromoproteÍna; cultura biologicamente pura de actinomadura sp. 21g792 (nrrl 30778); mÉtodo para preparar uma cromoproteÍna; mÉtodo para preparar uma cromoproteÍna modificada; mÉtodo para inibir a progressço de uma doenÇa neoplÁsica em um mamÍfero; composiÇço farmacÊutica; e composto | |
Ranganathan et al. | The whey acidic protein family: a new signature motif and three-dimensional structure by comparative modeling | |
Shoji et al. | The effect of intra-articular injection of microRNA-210 on ligament healing in a rat model | |
CN104630247B (zh) | 昆虫几丁质去乙酰基酶基因1及其在害虫防治中的应用 | |
BRPI0418025A (pt) | molécula de ácido nucléico isolada, cassette de expressão, vetor e métodos de expressão de sequências de nucleotìdeos em plantas e células de planta | |
Lai et al. | Transcriptomic analysis reveals specific osmoregulatory adaptive responses in gill mitochondria-rich cells and pavement cells of the Japanese eel | |
Sintsova et al. | Anti-inflammatory activity of a polypeptide from the Heteractis crispa sea anemone | |
Xu et al. | High‐Level Expression of a Soluble Functional Antimicrobial Peptide, Human β‐Defensin 2, in Escherichia coli | |
Sano et al. | Evolution of the teleostean zona pellucida gene inferred from the egg envelope protein genes of the Japanese eel, Anguilla japonica | |
Lau et al. | Draft genome of Brugia pahangi: high similarity between B. pahangi and B. malayi | |
O'Brien et al. | Molecular characterization of a third malic enzyme-like AP65 adhesin gene ofTrichomonas vaginalis | |
Schmitz et al. | Hyaluronan oligosaccharide treatment of chondrocytes stimulates expression of both HAS-2 and MMP-3, but by different signaling pathways | |
Finoshin et al. | Iron metabolic pathways in the processes of sponge plasticity | |
Dannfald et al. | Variations in transfer and ribosomal RNA epitranscriptomic status can adapt eukaryote translation to changing physiological and environmental conditions | |
Chigwechokha et al. | Nile Tilapia Neu3 sialidases: Molecular cloning, functional characterization and expression in Oreochromis niloticus | |
Moral-Sanz et al. | ERK and mTORC1 inhibitors enhance the anti-cancer capacity of the octpep-1 venom-derived peptide in melanoma BRAF (V600E) mutations | |
Zou et al. | Circ004463 promotes fibroblast proliferation and collagen I synthesis by sponging miR-23b and regulating CADM3/MAP4K4 via activation of AKT/ERK pathways | |
Liang et al. | Molecular cloning and functional characterization of cathepsin B from Nile tilapia (Oreochromis niloticus) | |
Yoshihara et al. | Superficial zone chondrocytes in normal and osteoarthritic human articular cartilages synthesize novel truncated forms of inter-alpha-trypsin inhibitor heavy chains which are attached to a chondroitin sulfate proteoglycan other than bikunin | |
Luo et al. | Molecular cloning and functional characterization of HMGB1 and HMGB2 in large yellow croaker Larimichthys crocea | |
Hwang et al. | Molecular characterization and gene expression data of liver expressed antimicrobial Peptide-2 (LEAP-2) isolated from rock bream (Oplegnathus fasciatus) | |
Ramos et al. | Different modes of binding of mono-and biaromatic effectors to the transcriptional regulator TTGV: role in differential derepression from its cognate operator | |
CN105848720A (zh) | 用于诱导葡萄糖摄取的方法 | |
Lu et al. | Population genomics of an icefish reveals mechanisms of glacier-driven adaptive radiation in Antarctic notothenioids | |
CN105492598A (zh) | 与细胞的抗衰老相关的生物分子群 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired |